| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| 2024 | 2022 | MYOGENE BIO LLC | 7098 MIRATECH DR STE 120 | SAN DIEGO | CA | 92121-3112 | SAN DIEGO | USA | R44AR075469 | Pre-clinical development of SPY-DYS45-55, a CRISPR/Cas9 platform for Duchenne muscular dystrophy | 000 | 3 | NIH | 12/18/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $499,207 ) |
| 2022 | 2022 | MYOGENE BIO LLC | 570 WESTWOOD PLZ STE 6350 | LOS ANGELES | CA | 90095-8352 | LOS ANGELES | USA | R44AR075469 | Pre-clinical development of SPY-DYS45-55, a CRISPR/Cas9 platform for Duchenne muscular dystrophy | 000 | 3 | NIH | 11/23/2021 | $499,207 |
| 2022 | 2020 | MYOGENE BIO LLC | 7098 MIRATECH DR STE 120 | SAN DIEGO | CA | 92121-3112 | SAN DIEGO | USA | R43AR078042 | Comparison of single versus dual vector delivery of AAV-SPY-DYS45-55 for Duchenne muscular dystrophy | 000 | 1 | NIH | 11/28/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| 2021 | 2020 | MYOGENE BIO LLC | 570 WESTWOOD PLZ STE 6350 | LOS ANGELES | CA | 90095-8352 | LOS ANGELES | USA | R44AR075469 | Pre-clinical development of SPY-DYS45-55, a CRISPR/Cas9 platform for Duchenne muscular dystrophy | 000 | 2 | NIH | 5/28/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $643,647 ) |
| 2020 | 2020 | MYOGENE BIO LLC | 570 WESTWOOD PLZ STE 6350 | LOS ANGELES | CA | 90095-8352 | LOS ANGELES | USA | R43AR078042 | Comparison of single versus dual vector delivery of AAV-SPY-DYS45-55 for Duchenne muscular dystrophy | 000 | 1 | NIH | 9/5/2020 | $149,919 |
| 2020 | 2020 | MYOGENE BIO LLC | 570 WESTWOOD PLZ STE 6350 | LOS ANGELES | CA | 90095-8352 | LOS ANGELES | USA | R44AR075469 | Pre-clinical development of SPY-DYS45-55, a CRISPR/Cas9 platform for Duchenne muscular dystrophy | 000 | 2 | NIH | 7/2/2020 | $493,728 |
| 2020 | 2019 | MYOGENE BIO LLC | 570 WESTWOOD PLZ STE 6350 | LOS ANGELES | CA | 90095-8352 | LOS ANGELES | USA | R44AR075469 | Pre-clinical development of SPY-DYS45-55, a CRISPR/Cas9 platform for Duchenne muscular dystrophy | 001 | 1 | NIH | 7/9/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $195,296 ) |
| 2019 | 2019 | MYOGENE BIO LLC | 1370 VETERAN AVE 208 | LOS ANGELES | CA | 90024-4850 | LOS ANGELES | USA | R44AR075469 | Pre-clinical development of SPY-DYS45-55, a CRISPR/Cas9 platform for Duchenne muscular dystrophy | 000 | 1 | NIH | 7/30/2019 | $195,296 |
|
|